Article
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.
Gastroenterology - 1 Aug 2008
Buster Erik H C J, Flink Hajo J, Cakaloglu Yilmaz, Simon Krzysztof, Trojan Jörg, Tabak Fehmi, So Thomas M K, Feinman S Victor, Mach Tomasz, Akarca Ulus S, Schutten Martin, Tielemans Wanda, van Vuuren Anneke J, Hansen Bettina E, Janssen Harry L A
Abstract excerpt
BACKGROUND & AIMS: The aim of this study was to evaluate the long-term sustainability of response in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B treated with pegylated interferon (PEG-IFN) alpha-2b alone or in combination with lamivudine. METHODS: All 266 patients enrolled in the HBV99-01 study were offered participation in a long-term follow-up (LTFU) study. Patients were treated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.